Is Eli Lilly Overpaying for Loxo Oncology?

stcks
Eternal

6 rules of successful biotech investing-"RESEARCH, RESEARCH, RESEARCH, PATIENCE, CAPITAL & RESEARCH"

Posts: 3,850

OPKO Investment: Long
Sentiment: Bullish
Recommendation: Hold

Is Eli Lilly Overpaying for Loxo Oncology? Jan 9, 2019 1:05:09 GMT via Tapatalk icemandios and c2crusher like this

Quote

Sales of LOXO-292 are expected to reach $800 million annually if approved. Eli Lilly will still need to funnel roughly 5% of LOXO-292 sales to Array Biopharma,

www.fool.com/amp/investing/2019/01/08/is-eli-lilly-overpaying-for-loxo-oncology.aspx?__twitter_impression=true

6 rules of successful biotech investing-"RESEARCH, RESEARCH, RESEARCH, PATIENCE, CAPITAL & RESEARCH"

Deleted Deleted Member Posts: 0 Apr 19, 2024 7:48:50 GMT	Is Eli Lilly Overpaying for Loxo Oncology? Jan 9, 2019 1:36:46 GMT Quote Select Post Deselect Post Link to Post Member Give Gift Back to Top Post by Deleted on Jan 9, 2019 1:36:46 GMT Pretty stupid buy, IMO. They should have bought ARRY, lots more potential. C L

opkfrostfan Supreme Member Posts: 690 Sept 30, 2015 17:48:29 GMT	Is Eli Lilly Overpaying for Loxo Oncology? Jan 9, 2019 10:59:06 GMT icemandios likes this Quote Select Post Deselect Post Link to Post Member Give Gift Back to Top Post by opkfrostfan on Jan 9, 2019 10:59:06 GMT Big Pharma still paying ~10X future revenue for strategic fits. It's been that way for years.

Where Due Diligence meets the Investor Connection